Background Insulinoma is the most common functional pancreatic neuroendocrine tumor
and treatment is required to address symptoms associated with insulin hypersecretion …

Background & Aims Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is
emerging as a safe and effective treatment for pancreatic neuroendocrine tumors. We aimed …

Background and Aims Insulinomas are among the most common types of functional
pancreatic neuroendocrine tumors and can cause debilitating, recurrent, symptomatic …

Background/objectives Insulinomas are rare, functioning pancreatic neuroendocrine
neoplasms (pNEN), whose gold standard therapy is surgical resection. Endoscopic …

Introduction Insulinomas are the most common functional pancreatic neuroendocrine tumors
(PNETs) that lead to incapacitating hypoglycemia. Guidelines recommend surgical resection …

Background and Aims Insulinoma is the most frequent functional neuroendocrine tumor of
the pancreas, and preserving surgery is the treatment of choice. EUS-guided radiofrequency …

Background and aims Most pancreatic insulinomas can be treated by minimally invasive
modalities. The aim of this meta-analysis was to assess the clinical outcomes of endoscopic …

BACKGROUND Endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA) has
recently been proposed as a local treatment for functional pancreatic neuroendocrine …

Objective In recent years, endoscopic ultrasoundguided radiofrequency ablation (EUS
RFA) has emerged as an alternative nonsurgical treatment for pancreatic neuroendocrine …

Background and Aims Insulinomas are one of the most common functional pancreatic
neuroendocrine tumors. Surgical removal is the standard of care. Patients unfit for or …